Follow
Karin Meeker
Karin Meeker
Washington University School of Medicine
Verified email at wustl.edu
Title
Cited by
Cited by
Year
Socioeconomic status mediates racial differences seen using the AT (N) framework
KL Meeker, JK Wisch, D Hudson, D Coble, C Xiong, GM Babulal, ...
Annals of neurology 89 (2), 254-265, 2021
522021
Sex-related differences in tau positron emission tomography (PET) and the effects of hormone therapy (HT)
JK Wisch, KL Meeker, BA Gordon, S Flores, A Dincer, EA Grant, ...
Alzheimer Disease & Associated Disorders 35 (2), 164-168, 2021
322021
Cerebrospinal fluid neurofilament light chain is a marker of aging and white matter damage
KL Meeker, OH Butt, BA Gordon, AM Fagan, SE Schindler, JC Morris, ...
Neurobiology of disease 166, 105662, 2022
272022
Modeling autosomal dominant Alzheimer's disease with machine learning
PH Luckett, A McCullough, BA Gordon, J Strain, S Flores, A Dincer, ...
Alzheimer's & Dementia 17 (6), 1005-1016, 2021
182021
Neuroimaging the Neuropathogenesis of HIV
AH Boerwinkle, KL Meeker, P Luckett, BM Ances
Current HIV/AIDS Reports 18, 221-228, 2021
132021
Cerebrospinal fluid Aβ42 moderates the relationship between brain functional network dynamics and cognitive intraindividual variability
KL Meeker, BM Ances, BA Gordon, CW Rudolph, P Luckett, DA Balota, ...
Neurobiology of aging 98, 116-123, 2021
132021
Network dysfunction in cognitively normal APOE ε4 carriers is related to subclinical tau
OH Butt, KL Meeker, JK Wisch, SE Schindler, AM Fagan, TLS Benzinger, ...
Alzheimer's & Dementia 18 (1), 116-126, 2022
72022
Modeling the effects of HIV and aging on resting-state networks using machine learning
PH Luckett, RH Paul, K Hannon, JJ Lee, JS Shimony, KL Meeker, ...
JAIDS Journal of Acquired Immune Deficiency Syndromes 88 (4), 414-419, 2021
62021
Resting state network mapping in individuals using deep learning
PH Luckett, JJ Lee, KY Park, RV Raut, KL Meeker, EM Gordon, AZ Snyder, ...
Frontiers in Neurology 13, 1055437, 2023
42023
Comparison of cerebrospinal fluid, plasma and neuroimaging biomarker utility in Alzheimer’s disease
KL Meeker, PH Luckett, NR Barthélemy, DA Hobbs, C Chen, J Bollinger, ...
Brain Communications 6 (2), fcae081, 2024
12024
Characterizing plasma biomarkers of the ATN framework among a diverse community‐dwelling cohort: A HABS‐HD study
M Petersen, F Zhang, J Hall, B Ances, A Cohen, KL Meeker, D Mason, ...
Alzheimer's & Dementia 19, e079110, 2023
2023
Effects of structural and social determinants of health and comorbidities on ethno‐racial differences in ATN plasma biomarkers of Alzheimer’s disease: A HABS‐HD study
KL Meeker, B Ances, M Petersen, R Barber, K Yaffe, Z Zhou, ...
Alzheimer's & Dementia 19, e078605, 2023
2023
A machine learning examination of the utility of CSF, neuroimaging, and plasma biomarkers in late onset Alzheimer Disease
KL Meeker, PH Luckett, NR Barthélemy, JJ Hassenstab, C Xiong, ...
Alzheimer's & Dementia 19, e070918, 2023
2023
CSF tau phosphorylation at sites 217 and 205 mediate the relationship between PET amyloid and downstream AD markers
KL Meeker, NR Barthélemy, BA Gordon, E McDade, CM Karch, AM Fagan, ...
Alzheimer's & Dementia 18, e065718, 2022
2022
Racial differences in Alzheimer biomarkers among early‐stage symptomatic and cognitively normal Alzheimer Disease Research Center (ADRC) participants
JC Morris, BM Ances, KL Meeker, SE Schindler, C Xiong, ...
Alzheimer's & Dementia 17, e052840, 2021
2021
Socioeconomic Status Mediates Racial Differences Seen Using the AT (N) Framework
JK Wisch, D Hudson, DW Coble, C Xiong, GM Babulal, BA Gordon, ...
2020 Alzheimer's Association International Conference, 2020
2020
The system can't perform the operation now. Try again later.
Articles 1–16